Enzo Biochem (ENZ) Reports Q2 Loss of 15c
Tweet Send to a FriendGet Alerts ENZ Hot Sheet
Price: $2.29 --0%
Revenue Growth %: -13.1%
Financial Fact:
Basic and diluted (in Dollars per share): -0.15
Today's EPS Names:
CLC, FNSR, MU, More
Revenue Growth %: -13.1%
Financial Fact:
Basic and diluted (in Dollars per share): -0.15
Today's EPS Names:
CLC, FNSR, MU, More
Trade ENZ Now!
Enzo Biochem Inc. (AMEX: ENZ) reports Q2 loss of $0.15, vs. the analyst estimate of ($0.10). Revenue for the quarter came in at $23.73 million, versus the consensus estimate of $24.16 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
- Adobe Systems, Inc. (ADBE) Tops Q2 EPS by 2c; Issues Q3 Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
